Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...
– Positive TNG462 clinical activity across multiple tumor types in the phase 1/2 clinical trial, program moving into full development with multiple combination studies – – Clinical collaboration...
– TNG462 demonstrated durable clinical activity across multiple tumor types, including non-small cell lung cancer (NSCLC) and pancreatic cancer, in ongoing phase 1/2 clinical trial, moving into...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.31 | 11.1111111111 | 2.79 | 3.28 | 2.715 | 2640123 | 3.01092928 | CS |
4 | -0.92 | -22.8855721393 | 4.02 | 4.21 | 2.7 | 1537462 | 3.14929626 | CS |
12 | -3.77 | -54.8762736536 | 6.87 | 7.4646 | 2.7 | 2016604 | 4.04132863 | CS |
26 | -6.04 | -66.0831509847 | 9.14 | 12.015 | 2.7 | 1406267 | 5.81234672 | CS |
52 | -7.07 | -69.5181907571 | 10.17 | 13.005 | 2.7 | 1031671 | 6.9094935 | CS |
156 | -7.85 | -71.6894977169 | 10.95 | 13.03 | 2.47 | 716111 | 7.1064052 | CS |
260 | -6.51 | -67.7419354839 | 9.61 | 18.84 | 2.47 | 659260 | 7.33220346 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.